Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance
- PMID: 22677645
- PMCID: PMC3443533
- DOI: 10.1038/oby.2012.126
Sphingolipid content of human adipose tissue: relationship to adiponectin and insulin resistance
Abstract
Ceramides (Cer) are implicated in obesity-associated skeletal muscle and perhaps adipocyte insulin resistance. We examined whether the sphingolipid content of human subcutaneous adipose tissue and plasma varies by obesity and sex as well as the relationship between ceramide content and metabolic indices. Abdominal subcutaneous adipose biopsies were performed on 12 lean adults (males = 6), 12 obese adults (males = 6) for measurement of sphingolipid content and activity of the main ceramide metabolism enzymes. Blood was sampled for glucose, insulin (to calculate homeostasis model assessment-estimated insulin resistance (HOMA(IR))) adiponectin, and interleukin-6 (IL-6) concentrations. Compared to lean controls, total ceramide content (pg/adipocyte) was increased by 31% (P < 0.05) and 34% (P < 0.05) in obese females and males, respectively. In adipocytes from obese adults sphingosine, sphinganine, sphingosine-1-phosphate, C14-Cer, C16-Cer, and C24-Cer were all increased. C18:1-Cer was increased in obese males and C24:1-Cer in obese females. For women only, there was a negative correlation between C16-Cer ceramide and plasma adiponectin (r = -0.77, P = 0.003) and a positive correlation between total ceramide content and HOMA(IR) (r = 0.74, P = 0.006). For men only there were significant (at least P < 0.05), positive correlations between adipocyte Cer-containing saturated fatty acid and plasma IL-6 concentration. We conclude that the sexual dimorphism in adipose tissue behavior in humans extends to adipose tissue sphingolipid content its association with adiponectin, IL-6 and insulin resistance.
Conflict of interest statement
The authors have no conflict of interest to disclose.
Figures
Similar articles
-
Ceramide metabolism is affected by obesity and diabetes in human adipose tissue.J Cell Physiol. 2012 Feb;227(2):550-7. doi: 10.1002/jcp.22745. J Cell Physiol. 2012. PMID: 21437908
-
Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome.Endocrine. 2012 Jun;41(3):442-9. doi: 10.1007/s12020-011-9589-4. Epub 2012 Jan 7. Endocrine. 2012. PMID: 22228496
-
Inhibition of Ceramide De Novo Synthesis Affects Adipocytokine Secretion and Improves Systemic and Adipose Tissue Insulin Sensitivity.Int J Mol Sci. 2018 Dec 11;19(12):3995. doi: 10.3390/ijms19123995. Int J Mol Sci. 2018. PMID: 30545025 Free PMC article.
-
Ceramides and Sphingosino-1-Phosphate in Obesity.Front Endocrinol (Lausanne). 2021 May 13;12:635995. doi: 10.3389/fendo.2021.635995. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34054722 Free PMC article. Review.
-
New role for ceramide in hypoxia and insulin resistance.World J Gastroenterol. 2020 May 14;26(18):2177-2186. doi: 10.3748/wjg.v26.i18.2177. World J Gastroenterol. 2020. PMID: 32476784 Free PMC article. Review.
Cited by
-
Improved insulin sensitivity after exercise training is linked to reduced plasma C14:0 ceramide in obesity and type 2 diabetes.Obesity (Silver Spring). 2015 Jul;23(7):1414-21. doi: 10.1002/oby.21117. Epub 2015 May 12. Obesity (Silver Spring). 2015. PMID: 25966363 Free PMC article. Clinical Trial.
-
The Impact of Phytochemicals in Obesity-Related Metabolic Diseases: Focus on Ceramide Metabolism.Nutrients. 2023 Jan 30;15(3):703. doi: 10.3390/nu15030703. Nutrients. 2023. PMID: 36771408 Free PMC article. Review.
-
Effects of meal ingestion on intramyocellular ceramide concentrations and fractional de novo synthesis in humans.Am J Physiol Endocrinol Metab. 2018 Feb 1;314(2):E105-E114. doi: 10.1152/ajpendo.00153.2017. Epub 2017 Sep 26. Am J Physiol Endocrinol Metab. 2018. PMID: 28970356 Free PMC article.
-
Increased dihydroceramide/ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function.Diabetes. 2015 Apr;64(4):1180-92. doi: 10.2337/db14-0359. Epub 2014 Oct 28. Diabetes. 2015. PMID: 25352638 Free PMC article.
-
The Impact of OMEGA-3 Fatty Acids Supplementation on Insulin Resistance and Content of Adipocytokines and Biologically Active Lipids in Adipose Tissue of High-Fat Diet Fed Rats.Nutrients. 2019 Apr 12;11(4):835. doi: 10.3390/nu11040835. Nutrients. 2019. PMID: 31013835 Free PMC article.
References
-
- Despres J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–887. - PubMed
-
- Lapidus L, Bengtsson C, Bjorntorp P. The quantitative relationship between"the metabolic syndrome " and abdominal obesity in women. Obes Res. 1994;2:372–377. - PubMed
-
- Axelsson J, Heimburger O, Lindholm B, Stenvinkel P. Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr. 2005;15:131–136. - PubMed
-
- Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes Relat Metab Disord. 2000;24(Suppl 4):S23–S27. - PubMed
-
- Verheij M, Bose R, Lin XH, et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 1996;380:75–79. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical